BOUNDLESS BIO, INC.: cashflow_investing
| Value | {"amount": 18137000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-03-31 |
| Status | current |
| Entity | BOUNDLESS BIO, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:37.803141+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/12c1b72d-1893-4d2a-9d63-ba0607981270
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-058188Retrieved: 2026-08-19T18:02:37.803141+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001782303/cashflow-investing/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/12c1b72d-1893-4d2a-9d63-ba0607981270
History
- no predecessors — first report